{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:55:55Z","timestamp":1791896155640,"version":"4.3.4"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013365","name":"West China Hospital, Sichuan University","doi-asserted-by":"publisher","award":["grant no. ZYGD21002"],"award-info":[{"award-number":["grant no. ZYGD21002"]}],"id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>This research sought to investigate the relationship between cognitive impairment and kynurenine pathway metabolites in individuals diagnosed with major depressive disorder (MDD). A total of 67 patients diagnosed with MDD and 61 healthy controls (HC) were enrolled in this study. Cognitive function was assessed utilizing the MATRICS Consensus Cognitive Battery. Plasma levels of tryptophan (TRP), kynurenine (KYN), kynurenic acid (KYNA), and quinolinic acid (QUIN) were quantified by liquid chromatography-tandem mass spectrometry. Subsequently, we examined the potential associations between metabolites of the KYN pathway and cognitive dysfunction. MDD patients exhibited significantly poorer performance across all cognitive domains, including processing speed, attention\/vigilance, working memory, verbal learning, visual learning, reasoning and problem-solving, and social cognition. Inter-group comparisons indicated that levels of KYN, QUIN, and the KYN\/TRP ratio in MDD patients were significantly lower than those in HC, whereas KYNA and the KYNA\/QUIN ratio were significantly higher. In MDD patients, a negative correlation was observed between KYN levels and working memory (r\u2009=\u2009\u22120.302, p\u2009=\u20090.020), and the KYN\/TRP ratio was also negatively correlated with working memory (r\u2009=\u2009\u22120.307, p\u2009=\u20090.018). Our findings indicate that impaired working memory in MDD is correlated with increased KYN levels and KYN\/TRP ratio. This suggests that the KYN pathway may play a role in the pathological mechanisms underlying neurocognitive dysfunction, particularly working memory deficits, in MDD.<\/jats:p>","DOI":"10.1371\/journal.pone.0328886","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T17:22:29Z","timestamp":1755537749000},"page":"e0328886","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Associations between Kynurenine pathway metabolites and cognitive dysfunction in major depressive disorder"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-3005-3605","authenticated-orcid":true,"given":"Yingying","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2439-6914","authenticated-orcid":true,"given":"Peiwei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueli","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,8,18]]},"reference":[{"issue":"11","key":"pone.0328886.ref001","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S2215-0366(21)00251-0","article-title":"Prevalence of depressive disorders and treatment in China: a cross-sectional epidemiological study","volume":"8","author":"J Lu","year":"2021","journal-title":"Lancet Psychiatry"},{"issue":"2","key":"pone.0328886.ref002","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/acps.13385","article-title":"Functional and cognitive impairment in the first episode of depression: A systematic review","volume":"145","author":"S Varghese","year":"2022","journal-title":"Acta Psychiatr Scand"},{"key":"pone.0328886.ref003","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.2147\/NDT.S195505","article-title":"Cognitive symptoms in major depressive disorder: associations with clinical and functional outcomes in a 6-month, non-interventional, prospective study in China","volume":"15","author":"G Wang","year":"2019","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"3","key":"pone.0328886.ref004","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1001\/jamapsychiatry.2018.3672","article-title":"Cognitive Performance in First-Degree Relatives of Individuals With vs Without Major Depressive Disorder: A Meta-analysis","volume":"76","author":"LE MacKenzie","year":"2019","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"pone.0328886.ref005","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/s41380-021-01379-5","article-title":"Genome-wide interaction study with major depression identifies novel variants associated with cognitive function","volume":"27","author":"A Thalamuthu","year":"2022","journal-title":"Mol Psychiatry"},{"issue":"10","key":"pone.0328886.ref006","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1017\/S0033291713002535","article-title":"Cognitive impairment in depression: a systematic review and meta-analysis","volume":"44","author":"PL Rock","year":"2014","journal-title":"Psychol Med"},{"issue":"1","key":"pone.0328886.ref007","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/YCO.0000000000000378","article-title":"Cognitive dysfunction in major depressive disorder","volume":"31","author":"MJ Knight","year":"2018","journal-title":"Current Opinion in Psychiatry"},{"issue":"1","key":"pone.0328886.ref008","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/s41398-022-02240-1","article-title":"Evaluating cognitive disturbances as treatment target and predictor of antidepressant action in major depressive disorder: A NeuroPharm study","volume":"12","author":"VH Dam","year":"2022","journal-title":"Transl Psychiatry"},{"issue":"1","key":"pone.0328886.ref009","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/s41398-022-02249-6","article-title":"Pharmacological targeting of cognitive impairment in depression: recent developments and challenges in human clinical research","volume":"12","author":"MJ Colwell","year":"2022","journal-title":"Transl Psychiatry"},{"issue":"14","key":"pone.0328886.ref010","doi-asserted-by":"crossref","first-page":"6611","DOI":"10.1017\/S0033291722004007","article-title":"Cognitive performance and brain structural connectome alterations in major depressive disorder","volume":"53","author":"M Gruber","year":"2023","journal-title":"Psychol Med"},{"key":"pone.0328886.ref011","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jad.2019.03.042","article-title":"Depression related cerebral pathology and its relationship with cognitive functioning: A systematic review","volume":"250","author":"A Jamieson","year":"2019","journal-title":"Journal of Affective Disorders"},{"issue":"3","key":"pone.0328886.ref012","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1124\/pr.117.014977","article-title":"International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets","volume":"70","author":"F Caraci","year":"2018","journal-title":"Pharmacological Reviews"},{"issue":"8","key":"pone.0328886.ref013","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1038\/s41380-022-01582-y","article-title":"The relationship between immune and cognitive dysfunction in mood and psychotic disorder: a systematic review and a meta-analysis","volume":"27","author":"M Morrens","year":"2022","journal-title":"Mol Psychiatry"},{"issue":"5","key":"pone.0328886.ref014","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S2215-0366(15)00579-9","article-title":"Precision psychiatry: a neural circuit taxonomy for depression and anxiety","volume":"3","author":"LM Williams","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"5","key":"pone.0328886.ref015","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.euroneuro.2013.04.013","article-title":"Developments in the field of antidepressants, where do we go now?","volume":"25","author":"F Artigas","year":"2015","journal-title":"Eur Neuropsychopharmacol"},{"issue":"6","key":"pone.0328886.ref016","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s12264-021-00638-3","article-title":"Major Depressive Disorder: Advances in Neuroscience Research and Translational Applications","volume":"37","author":"Z Li","year":"2021","journal-title":"Neurosci Bull"},{"key":"pone.0328886.ref017","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.neubiorev.2021.05.018","article-title":"The kynurenine pathway in major depression: What we know and where to next","volume":"127","author":"SJ Brown","year":"2021","journal-title":"Neuroscience & Biobehavioral Reviews"},{"key":"pone.0328886.ref018","doi-asserted-by":"crossref","first-page":"100537","DOI":"10.1016\/j.bbih.2022.100537","article-title":"The tryptophan catabolite or kynurenine pathway in major depressive and bipolar disorder: A systematic review and meta-analysis","volume":"26","author":"AF Almulla","year":"2022","journal-title":"Brain Behav Immun Health"},{"issue":"5","key":"pone.0328886.ref019","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41573-019-0016-5","article-title":"Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond","volume":"18","author":"M Platten","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"pone.0328886.ref020","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.neuropharm.2016.05.020","article-title":"The kynurenine pathway in schizophrenia and bipolar disorder","volume":"112","author":"S Erhardt","year":"2017","journal-title":"Neuropharmacology"},{"issue":"6","key":"pone.0328886.ref021","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/jnc.14907","article-title":"Does kynurenic acid act on nicotinic receptors? An assessment of the evidence","volume":"152","author":"TW Stone","year":"2019","journal-title":"Journal of Neurochemistry"},{"issue":"5","key":"pone.0328886.ref022","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70197","article-title":"Kynurenine pathway metabolite alterations in Down syndrome and Alzheimer\u2019s disease","volume":"21","author":"RG Dos Reis","year":"2025","journal-title":"Alzheimers Dement"},{"issue":"1","key":"pone.0328886.ref023","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12888-023-04520-6","article-title":"Tryptophan catabolites and depression in the general population: results from the Gutenberg Health Study","volume":"23","author":"M Michal","year":"2023","journal-title":"BMC Psychiatry"},{"key":"pone.0328886.ref024","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.psyneuen.2018.11.001","article-title":"Cross-sectional relationship between kynurenine pathway metabolites and cognitive function in major depressive disorder","volume":"101","author":"Y Zhou","year":"2019","journal-title":"Psychoneuroendocrinology"},{"issue":"6","key":"pone.0328886.ref025","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s00406-022-01519-0","article-title":"Importance of the dysregulation of the kynurenine pathway on cognition in schizophrenia: a systematic review of clinical studies","volume":"273","author":"J Sapienza","year":"2023","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"1","key":"pone.0328886.ref026","doi-asserted-by":"crossref","first-page":"9992","DOI":"10.1038\/s41598-021-89335-9","article-title":"Quinolinic acid is associated with cognitive deficits in schizophrenia but not major depressive disorder","volume":"11","author":"F Cathomas","year":"2021","journal-title":"Sci Rep"},{"key":"pone.0328886.ref027","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bbi.2017.08.024","article-title":"Kynurenic acid is reduced in females and oral contraceptive users: Implications for depression","volume":"67","author":"TB Meier","year":"2018","journal-title":"Brain Behav Immun"},{"issue":"2","key":"pone.0328886.ref028","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1176\/appi.ajp.2007.07010042","article-title":"The MATRICS Consensus Cognitive Battery, Part 1: Test Selection, Reliability, and Validity","volume":"165","author":"KH Nuechterlein","year":"2008","journal-title":"AJP"},{"key":"pone.0328886.ref029","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jad.2020.01.052","article-title":"Psychometric properties of the MATRICS Consensus Cognitive Battery (MCCB) in Chinese patients with major depressive disorder","volume":"265","author":"S Liang","year":"2020","journal-title":"J Affect Disord"},{"key":"pone.0328886.ref030","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.schres.2015.09.003","article-title":"The MATRICS Consensus Cognitive Battery (MCCB): Co-norming and standardization in China","volume":"169","author":"C Shi","year":"2015","journal-title":"Schizophr Res"},{"key":"pone.0328886.ref031","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jad.2015.03.021","article-title":"Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials","volume":"180","author":"Y Hayasaka","year":"2015","journal-title":"J Affect Disord"},{"key":"pone.0328886.ref032","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.neubiorev.2018.05.031","article-title":"Role of Kynurenine pathway and its metabolites in mood disorders: A systematic review and meta-analysis of clinical studies","volume":"92","author":"D Arnone","year":"2018","journal-title":"Neuroscience & Biobehavioral Reviews"},{"issue":"4","key":"pone.0328886.ref033","doi-asserted-by":"crossref","first-page":"141","DOI":"10.5498\/wjp.v13.i4.141","article-title":"Kynurenine pathway of tryptophan metabolism in pathophysiology and therapy of major depressive disorder","volume":"13","author":"AA-B Badawy","year":"2023","journal-title":"World J Psychiatry"},{"issue":"1","key":"pone.0328886.ref034","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2174\/1871527319666200102100307","article-title":"Plasma Indoleamine-2,3-Dioxygenase (IDO) is Increased in Drug-Na\u00ef ve Major Depressed Patients and Treatment with Sertraline and Ketoprofen Normalizes IDO in Association with Pro-Inflammatory and Immune- Regulatory Cytokines","volume":"19","author":"HK Al-Hakeim","year":"2020","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"6349","key":"pone.0328886.ref035","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf9794","article-title":"Kynurenines: Tryptophan\u2019s metabolites in exercise, inflammation, and mental health","volume":"357","author":"I Cervenka","year":"2017","journal-title":"Science"},{"issue":"2","key":"pone.0328886.ref036","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/pcn.12944","article-title":"Peripheral tryptophan, serotonin, kynurenine, and their metabolites in major depression: A case-control study","volume":"74","author":"R Colle","year":"2020","journal-title":"Psychiatry Clin Neurosci"},{"key":"pone.0328886.ref037","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.neubiorev.2020.08.010","article-title":"Effect of immune activation on the kynurenine pathway and depression symptoms - A systematic review and meta-analysis","volume":"118","author":"C Hunt","year":"2020","journal-title":"Neurosci Biobehav Rev"},{"key":"pone.0328886.ref038","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.neuropharm.2015.11.015","article-title":"Tryptophan availability for kynurenine pathway metabolism across the life span: Control mechanisms and focus on aging, exercise, diet and nutritional supplements","volume":"112","author":"AA-B Badawy","year":"2017","journal-title":"Neuropharmacology"},{"issue":"12","key":"pone.0328886.ref039","doi-asserted-by":"crossref","DOI":"10.3945\/jn.111.157065","article-title":"Effects and Side Effects Associated with the Non-Nutritional Use of Tryptophan by Humans","volume":"142","author":"JD Fernstrom","year":"2012","journal-title":"The Journal of Nutrition"},{"key":"pone.0328886.ref040","doi-asserted-by":"crossref","first-page":"110226","DOI":"10.1016\/j.pnpbp.2020.110226","article-title":"Activation and deactivation steps in the tryptophan breakdown pathway in major depressive disorder: A link to the monocyte inflammatory state of patients","volume":"107","author":"G Arteaga-Henriquez","year":"2021","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"19","key":"pone.0328886.ref041","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.3390\/cells11193112","article-title":"The Tryptophan Catabolite or Kynurenine Pathway in a Major Depressive Episode with Melancholia, Psychotic Features and Suicidal Behaviors: A Systematic Review and Meta-Analysis","volume":"11","author":"AF Almulla","year":"2022","journal-title":"Cells"},{"issue":"21","key":"pone.0328886.ref042","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.2174\/1568026622666220428095250","article-title":"The Tryptophan Catabolite or Kynurenine Pathway\u2019s Role in Major Depression","volume":"22","author":"AF Almulla","year":"2022","journal-title":"CTMC"},{"key":"pone.0328886.ref043","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.neuropharm.2016.01.034","article-title":"Kynurenine pathway metabolites and suicidality","volume":"112","author":"EY Bryleva","year":"2017","journal-title":"Neuropharmacology"},{"issue":"5","key":"pone.0328886.ref044","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/npp.2012.248","article-title":"Connecting inflammation with glutamate agonism in suicidality","volume":"38","author":"S Erhardt","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"pone.0328886.ref045","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.bbi.2014.07.012","article-title":"A role for inflammatory metabolites as modulators of the glutamate N-methyl-D-aspartate receptor in depression and suicidality","volume":"43","author":"C Bay-Richter","year":"2015","journal-title":"Brain Behav Immun"},{"issue":"1","key":"pone.0328886.ref046","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41398-021-01610-5","article-title":"Alterations of kynurenine pathway in alcohol use disorder and abstinence: a link with gut microbiota, peripheral inflammation and psychological symptoms","volume":"11","author":"S Leclercq","year":"2021","journal-title":"Transl Psychiatry"},{"key":"pone.0328886.ref047","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.schres.2013.09.004","article-title":"The effect of transient increases in kynurenic acid and quinolinic acid levels early in life on behavior in adulthood: Implications for schizophrenia","volume":"150","author":"HF Iaccarino","year":"2013","journal-title":"Schizophr Res"},{"key":"pone.0328886.ref048","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bbi.2015.06.022","article-title":"Indoleamine 2,3-dioxygenase-dependent neurotoxic kynurenine metabolism mediates inflammation-induced deficit in recognition memory","volume":"50","author":"JM Heisler","year":"2015","journal-title":"Brain Behav Immun"},{"key":"pone.0328886.ref049","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.psychres.2018.08.041","article-title":"Kynurenine pathway changes in late-life depression with memory deficit","volume":"269","author":"Y Wu","year":"2018","journal-title":"Psychiatry Res"},{"key":"pone.0328886.ref050","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.schres.2013.09.004","article-title":"The effect of transient increases in kynurenic acid and quinolinic acid levels early in life on behavior in adulthood: Implications for schizophrenia","volume":"150","author":"HF Iaccarino","year":"2013","journal-title":"Schizophr Res"},{"key":"pone.0328886.ref051","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bbi.2015.06.022","article-title":"Indoleamine 2,3-dioxygenase-dependent neurotoxic kynurenine metabolism mediates inflammation-induced deficit in recognition memory","volume":"50","author":"JM Heisler","year":"2015","journal-title":"Brain Behav Immun"},{"key":"pone.0328886.ref052","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fncel.2020.00011","article-title":"Indoleamine-2,3-Dioxygenase Mediates Emotional Deficits by the Kynurenine\/Tryptophan Pathway in the Ethanol Addiction\/Withdrawal Mouse Model","volume":"14","author":"X Jiang","year":"2020","journal-title":"Front Cell Neurosci"},{"key":"pone.0328886.ref053","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.psyneuen.2018.10.010","article-title":"Probiotic Lactobacillus Plantarum 299v decreases kynurenine concentration and improves cognitive functions in patients with major depression: A double-blind, randomized, placebo controlled study","volume":"100","author":"L Rudzki","year":"2019","journal-title":"Psychoneuroendocrinology"},{"issue":"9","key":"pone.0328886.ref054","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1038\/s41380-022-01552-4","article-title":"The tryptophan catabolite or kynurenine pathway in schizophrenia: meta-analysis reveals dissociations between central, serum, and plasma compartments","volume":"27","author":"AF Almulla","year":"2022","journal-title":"Mol Psychiatry"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0328886","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T17:22:37Z","timestamp":1755537757000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0328886"}},"subtitle":[],"editor":[{"given":"Rosemary","family":"Bassey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,8,18]]},"references-count":54,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0328886","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,18]]}}}